Replies to post #108 on Zyla Life Sciences (fka ZCOR)

[realfast95]

thanks for the article. The quote was in the article as you said.
Unfortunately they misquoted. She never said it in the interview.
I just listened to it.

The company said they needed more time. Nothing about labeling.

But that's not what happened Thursday. The hangup appears to be on the drug's labeling, which Russo said is just the product of them being overly cautious.

It was worth my time to listen to it. She definitely likes the company.
It makes my investment feel safer. I wanted to be all cash before the election. Tough decisions.

Next up. look at the other companies she mentioned and compare them to EGLT